Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-06

Clinical Trial Update: Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bromfenac ophthalmic solution for pain and inflammation following cataract surgery; the study results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Pain, Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2014-05-06